In the world of brain tumor pathology, few molecular findings carry as much practical weight as MGMT promoter methylation. When a pathology report mentions that the MGMT gene promoter is methylated (or “silenced”), it often signals better news than the…
Brain cancer, particularly gliomas, remains one of the most challenging diagnoses a person can face, yet advances in molecular understanding have brought new hope to patients and families. Among the most significant breakthroughs is the discovery of IDH mutations in…
A brain tumor diagnosis often begins with one number that carries enormous weight: the WHO grade. That single digit from 1 to 4 tells doctors, and patients, how aggressively the tumor is likely to behave, how quickly it may grow,…
